Mapping protein-RNA interactions

Virus Adaptation and Treatment

Volumn 4, Issue 1, 2012, Pages 29-41

  Vaughan, Robert ^a   Running, William ^a   Qi, Rongsu ^a   Cheng Kao, C ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Hepatitis C virus; Mass spectrometry; Positive strand RNA virus; Reversible crosslinking; RNA binding

Indexed keywords

CROSS LINKING REAGENT; VIRUS RNA;

AMINO TERMINAL SEQUENCE; CROSS LINKING; CRYSTAL STRUCTURE; ENZYME ACTIVITY; GENE MAPPING; HEPATITIS C VIRUS; HUMAN; INNATE IMMUNITY; MASS SPECTROMETRY; MUTATION RATE; NONHUMAN; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN RNA BINDING; PROTEIN TERTIARY STRUCTURE; PURIFICATION; REVERSIBLE CROSS LINKING AFFINITY PURIFICATION; REVIEW; RNA TRANSLATION; VIRUS CAPSID; VIRUS PARTICLE;

EID: 84864303303     PISSN: None     EISSN: 11791624     Source Type: Journal    
DOI: 10.2147/VAAT.S31299     Document Type: Review

References (93)

1. Liu S, Ghalei H, Luhrmann R, Wahl MC. Structural basis for the dual U4 and U4atac snRNA-binding specificity of spliceosomal protein hPrp31. RNA. 2011;17(9):1655-1663.
2. Leung AK, Nagai K, Li J. Structure of the spliceosomal U4 snRNP core domain and its implication for snRNP biogenesis. Nature. 2011;473(7348):536-539.
3. Schuwirth BS, Borovinskaya MA, Hau CW, et al. Structures of the bacterial ribosome at 3.5 A resolution. Science. 2005;310(5749):827-834.
4. Fisher AJ, Johnson JE. Ordered duplex RNA controls capsid architecture in an icosahedral animal virus. Nature. 1993;361(6408):176-179.
5. Wery JP, Reddy VS, Hosur MV, Johnson JE. The refined threedimensional structure of an insect virus at 2.8 A resolution. J Mol Biol. 1994;235(2):565-586.
6. Scherrer T, Mittal N, Janga SC, Gerber AP. A screen for RNA-binding proteins in yeast indicates dual functions for many enzymes. PloS One. 2010;5(11):e15499.
7. Tsvetanova NG, Klass DM, Salzman J, Brown PO. Proteome-wide search reveals unexpected RNA-binding proteins in Saccharomyces cerevisiae. PloS One. 2010;5(9):e12671.
8. Hwang J, Huang L, Cordek DG, et al. Hepatitis C virus nonstructural protein 5A: biochemical characterization of a novel structural class of RNA-binding proteins. J Virol. 2010;84(24): 12480-12491.
9. Ranjith-Kumar CT, Duffy KE, Jordan JL, et al. Single-stranded oligonucleotides can inhibit cytokine production induced by human toll-like receptor 3. Mol Cell Biol. 2008;28(14):4507-4519.
10. Ranjith-Kumar CT, Murali A, Dong W, et al. Agonist and antagonist recognition by RIG-I, a cytoplasmic innate immunity receptor. J Biol Chem. 2009;284(2):1155-1165.
11. Yi G, Vaughan RC, Yarbrough I, Dharmaiah S, Kao CC. RNA binding by the brome mosaic virus capsid protein and the regulation of viral RNA accumulation. J Mol Biol. 2009;391(2):314-326.
12. Kim YC, Russell WK, Ranjith-Kumar CT, Thomson M, Russell DH, Kao CC. Functional analysis of RNA binding by the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem. 2005;280(45):38011-38019.
13. Ascano M, Hafner M, Cekan P, Gerstberger S, Tuschl T. Identification of RNA-protein interaction networks using PAR-CLIP. Wiley Interdiscip Rev RNA. 2012;3(2):159-177.
14. Hafner M, Landthaler M, Burger L, et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010;141(1):129-141.
15. Hafner M, Landthaler M, Burger L, et al. PAR-CliP - a method to identify transcriptome-wide the binding sites of RNA binding proteins. J Vis Exp. 2010;41:2034.
16. Orlando V, Strutt H, Paro R. Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods. 1997;11(2):205-214.
17. Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco MA. Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods. 2002;26(2):182-190.
18. Collas P. The current state of chromatin immunoprecipitation. Mol Biotechnol. 2010;45(1):87-100.
19. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999;20(18):3551-3567.
20. Clauser KR, Baker P, Burlingame AL. Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal Chem. 1999;71(14):2871-2882.
21. Poenisch M, Bartenschlager R. New insights into structure and replication of the hepatitis C virus and clinical implications. Semin Liver Dis. 2010;30(4):333-347.
22. Chinnaswamy S, Cai H, Kao C. An update on small molecule inhibitors of the HCV NS5B polymerase: effects on RNA synthesis in vitro and in cultured cells, and potential resistance in viral quasispecies. Virus Adaptation and Treatment. 2010;2(1):73-89.
23. Chinnaswamy S, Murali A, Li P, Fujisaki K, Kao CC. Regulation of de novo-initiated RNA synthesis in hepatitis C virus RNA-dependent RNA polymerase by intermolecular interactions. J Virol. 2010;84(12):5923-5935.
24. Chinnaswamy S, Yarbrough I, Palaninathan S, et al. A locking mechanism regulates RNA synthesis and host protein interaction by the hepatitis C virus polymerase. J Biol Chem. 2008;283(29): 20535-20546.
25. O'Farrell D, Trowbridge R, Rowlands D, Jager J. Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): structural evidence for nucleotide import and de-novo initiation. J Mol Biol. 2003;326(4):1025-1035.
26. Lee JH, Nam IY, Myung H. Nonstructural protein 5B of hepatitis C virus. Mol Cells. 2006;21(3):330-336.
27. Kao CC, Yang X, Kline A, Wang QM, Barket D, Heinz BA. Template requirements for RNA synthesis by a recombinant hepatitis C virus RNA-dependent RNA polymerase. J Virol. 2000;74(23):11121-11128.
28. Lan KH, Sheu ML, Hwang SJ, et al. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene. 2002;21(31):4801-4811.
29. Wang J, Tong W, Zhang X, et al. Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cells. FEBS Lett. 2006;580(18):4392-4400.
30. Shirota Y, Luo H, Qin W, et al. Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity. J Biol Chem. 2002;277(13):11149-11155.
31. Ahn J, Chung KS, Kim DU, et al. Systematic identification of hepatocellular proteins interacting with NS5A of the hepatitis C virus. J Biochem Mol Biol. 2004;37(6):741-748.
32. Fridell RA, Wang C, Sun JH, et al. Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in humans: in vitro and in vivo correlations. Hepatology. 2011;54(6):1924-1935.
33. Tellinghuisen TL, Marcotrigiano J, Rice CM. Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature. 2005;435(7040):374-379.
34. Li X, Romero P, Rani M, Dunker AK, Obradovic Z. Predicting protein disorder for N-, C-, and internal regions. Genome Inform Ser Workshop Genome Inform. 1999;10:30-40.
35. Frick DN, Rypma RS, Lam AM, Gu B. The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently. J Biol Chem. 2004;279(2):1269-1280.
36. Gu B, Pruss CM, Gates AT, Khandekar SS. The RNA-unwinding activity of hepatitis C virus non-structural protein 3 (NS3) is positively modulated by its protease domain. Protein Pept Lett. 2005;12(4): 315-321.
37. Zhang C, Cai Z, Kim YC, et al. Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase. J Virol. 2005;79(14):8687-8697.
38. Hwang J, Fauzi H, Fukuda K, et al. The RNA aptamer-binding site of hepatitis C virus NS3 protease. Biochem Biophys Res Commun. 2000;279(2):557-562.
39. Kim JL, Morgenstern KA, Griffith JP, et al. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure. 1998;6(1):89-100.
40. Appleby TC, Anderson R, Fedorova O, et al. Visualizing ATP-dependent RNA translocation by the NS3 helicase from HCV. J Mol Biol. 2011;405(5):1139-1153.
41. Yakovlev AA. Crosslinkers and their utilization for studies ofintermolecular interactions. Neurochem J. 2009;3(2):139-144.
42. Metz B, Kersten GF, Hoogerhout P, et al. Identification of formaldehyde- induced modifications in proteins: reactions with model peptides. J Biol Chem. 2004;279(8):6235-6243.
43. Lu K, Ye W, Zhou L, et al. Structural characterization of formaldehyde-induced cross-links between amino acids and deoxynucleosides and their oligomers. J Am Chem Soc. 2010;132(10):3388-3399.
44. Toth J, Biggin MD. The specificity of protein-DNA crosslinking by formaldehyde: in vitro and in drosophila embryos. Nucleic Acids Res. 2000;28(2):e4.
45. Zhang L, Zhang K, Prandl R, Schoffl F. Detecting DNA-binding of proteins in vivo by UV-crosslinking and immunoprecipitation. Biochem Biophys Res Commun. 2004;322(3):705-711.
46. Jones S, Daley DT, Luscombe NM, Berman HM, Thornton JM. Protein-RNA interactions: a structural analysis. Nucleic Acids Res. 2001;29(4):943-954.
47. Smith AL, Friedman DB, Yu H, Carnahan RH, Reynolds AB. ReCLIP (reversible cross-link immuno-precipitation): an efficient method for interrogation of labile protein complexes. PloS One. 2011;6(1):e16206.
48. Piran U, Riordan WJ. Dissociation rate constant of the biotin- streptavidin complex. JImmunol Methods. 1990;133(1):141-143.
49. Hnatowich DJ, Winnard P Jr, Virzi F, et al. Technetium-99 m labeling of DNA oligonucleotides. J Nucl Med. 1995;36(12):2306-2314.
50. Kalkhof S, Sinz A. Chances and pitfalls of chemical cross-linking with amine-reactive N-hydroxysuccinimide esters. Anal Bioanal Chem. 2008;392(1-2):305-312.
51. Morpurgo M, Bayer EA, Wilchek M. N-hydroxysuccinimide carbonates and carbamates are useful reactive reagents for coupling ligands to lysines on proteins. J Biochem Biophys Methods. 1999;38(1): 17-28.
52. Barlow JJ, Mathias AP, Williamson R, Gammack DB. A simple method for the quantitative isolation of undegraded high molecular weight ribonucleic acid. Biochem Biophys Res Commun. 1963;13:61-66.
53. Cathala G, Savouret JF, Mendez B, et al. A method for isolation ofintact, translationally active ribonucleic acid. DNA. 1983;2(4):329-335.
54. Auffray C, Rougeon F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem. 1980;107(2):303-314.
55. Ferrer-Orta C, Arias A, Escarmis C, Verdaguer N. A comparison of viral RNA-dependent RNA polymerases. Curr Opin Struct Biol. 2006;16(1):27-34.
56. Kolb HC, Finn MG, Sharpless KB. Click chemistry: diverse chemical function from a few good reactions. Angew Chem Int Ed Engl. 2001;40(11):2004-2021.
57. Speers AE, Cravatt BF. Profiling enzyme activities in vivo using click chemistry methods. Chem Biol. 2004;11(4):535-546.
58. Deval J, D'Abramo CM, Zhao Z, et al. High resolution footprinting of the hepatitis C virus polymerase NS5B in complex with RNA. J Biol Chem. 2007;282(23):16907-16916.
59. Running WE, Reilly JP. Ribosomal proteins of Deinococcus radiodurans: their solvent accessibility and reactivity. J Proteome Res. 2009;8(3):1228-1246.
60. Lauber MA, Reilly JP. Structural analysis of a prokaryotic ribosome using a novel amidinating cross-linker and mass spectrometry. J Proteome Res. 2011;10(8):3604-3616.
61. Lundblad RL. Chemical Reagents for Protein Modification, 3rd ed. Boca Raton, FL: CRC Press; 2005.
62. Mendoza VL, Vachet RW. Probing protein structure by amino acid- specific covalent labeling and mass spectrometry. Mass Spectrom Rev. 2009;28(5):785-815.
63. Kannan N, Schneider TD, Vishveshwara S. Logos for amino-acid preferences in different backbone packing density regions of protein structural classes. Acta Crystallogr D Biol Crystallogr. 2000;56(Pt 9): 1156-1165.
64. Carven GJ, Stern LJ. Probing the ligand-induced conformational change in HLA-DR1 by selective chemical modification and mass spectrometric mapping. Biochemistry. 2005;44(42):13625-13637.
65. Suckau D, Mak M, Przybylski M. Protein surface topology-probing by selective chemical modification and mass spectrometric peptide mapping. Proc Natl Acad Sci U S A. 1992;89(12): 5630-5634.
66. Habeeb AF, Cassidy HG, Singer SJ. Molecular structural effects produced in proteins by reaction with succinic anhydride. Biochim Biophys Acta. 1958;29(3):587-593.
67. Janecki DJ, Beardsley RL, Reilly JP. Probing protein tertiary structure with amidination. Anal Chem. 2005;77(22):7274-7281.
68. Inman JK, Perham RN, DuBois GC, Appella E. Amidination. Methods Enzymol. 1983;91:559-569.
69. Liu X, Reilly JP. Correlating the chemical modification of Escherichia coli ribosomal proteins with crystal structure data. J Proteome Res. 2009;8(10):4466-4478.
70. Reynolds JH. Acetimidation of bovine pancreatic ribonuclease A. Biochemistry. 1968;7(9):3131-3135.
71. Fazili KM, Mir MM, Qasim MA. Changes in protein stability upon chemical modification of lysine residues of bovine serum albumin by different reagents. Biochem Mol Biol Int. 1993;31(5):807-816.
72. Thumm M, Hoenes J, Pfleiderer G. S-methylthioacetimidate is a new reagent for the amidination of proteins at low pH. Biochim Biophys Acta. 1987;923(2):263-267.
73. Beardsley RL, Reilly JP. Quantitation using enhanced signal tags: a technique for comparative proteomics. J Proteome Res. 2003;2(1): 15-21.
74. Meisenheimer KM, Koch TH. Photocross-linking of nucleic acids to associated proteins. Crit Rev Biochem Mol Biol. 1997;32(2): 101-140.
75. Steen H, Jensen ON. Analysis of protein-nucleic acid interactions by photochemical cross-linking and mass spectrometry. Mass Spectrom Rev. 2002;21(3):163-182.
76. Urlaub H, Hartmuth K, Luhrmann R. A two-tracked approach to analyze RNA-protein crosslinking sites in native, nonlabeled small nuclear ribonucleoprotein particles. Methods. 2002;26(2):170-181.
77. Kuhn-Holsken E, Dybkov O, Sander B, Luhrmann R, Urlaub H. Improved identification of enriched peptide RNA cross-links from ribonucleoprotein particles (RNPs) by mass spectrometry. Nucleic Acids Res. 2007;35(15):e95.
78. Kuhn-Holsken E, Lenz C, Sander B, Luhrmann R, Urlaub H. Complete MALDI-ToF MS analysis of cross-linked peptide-RNA oligo-nucleotides derived from nonlabeled UV-irradiated ribonucleoprotein particles. RNA. 2005;11(12):1915-1930.
79. Lenz C, Kuhn-Holsken E, Urlaub H. Detection of protein-RNA crosslinks by NanoLC-ESI-MS/MS using precursor ion scanning and multiple reaction monitoring (MRM) experiments. J Am Soc Mass Spectrom. 2007;18(5):869-881.
80. Jensen ON, Kulkarni S, Aldrich JV, Barofsky DF. Characterization of peptide-oligonucleotide heteroconjugates by mass spectrometry. Nucleic Acids Res. 1996;24(19):3866-3872.
81. Geyer H, Geyer R, Pingoud V. A novel strategy for the identification of protein-DNA contacts by photocrosslinking and mass spectrometry. Nucleic Acids Res. 2004;32(16):e132.
82. Golden MC, Resing KA, Collins BD, Willis MC, Koch TH. Mass spectral characterization of a protein-nucleic acid photocrosslink. Protein Sci. 1999;8(12):2806-2812.
83. Martin Richter F, Hsiao HH, Plessmann U, Urlaub H. Enrichment of protein-RNA crosslinks from crude UV-irradiated mixtures for MS analysis by on-line chromatography using titanium dioxide columns. Biopolymers. 2009;91(4):297-309.
84. Krivos KL, Limbach PA. Sequence analysis of peptide:oligonucleotide heteroconjugates by electron capture dissociation and electron transfer dissociation. J Am Soc Mass Spectrom. 2010;21(8):1387-1397.
85. Licatalosi DD, Darnell RB. RNA processing and its regulation: global insights into biological networks. Nat Rev Genet. 2010;11(1):75-87.
86. Weeks KM, Mauger DM. Exploring RNA structural codes with SHAPE chemistry. Acc Chem Res. 2011;44(12):1280-1291.
87. Skalsky RL, Corcoran DL, Gottwein E, et al. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog. 2012;8(1):e1002484.
88. Malterer G, Dolken L, Haas J. The miRNA-targetome of KSHV and EBV in human B-cells. RNA Biol. 2011;8(1):30-34.
89. Lebedeva S, Jens M, Theil K, et al. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol Cell. 2011;43(3):340-352.
90. Jungkamp AC, Stoeckius M, Mecenas D, et al. In vivo and transcriptome- wide identification of RNA binding protein target sites. Mol Cell. 2011;44(5):828-840.
91. Hoell JI, Larsson E, Runge S, et al. RNA targets of wild-type and mutant FET family proteins. Nat Struct Mol Biol. 2011;18(12):1428-1431.
92. Gottwein E, Corcoran DL, Mukherjee N, et al. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe. 2011;10(5):515-526.
93. Shepherd CM, Borelli IA, Lander G, et al. VIPERdb: a relational database for structural virology. Nucleic Acids Res. 2006;34(Database issue): D386-D389.